1. A low-carbohydrate high-fat (LCHF) diet improved glycemic and weight control in patients with type two diabetes mellitus (T2DM) compared ...
1. In patients with type 2 diabetes and hypertriglyceridemia, pemafibrate did not alter the incidence of cardiovascular events compared to placebo. ...
1. SGLT2 inhibitors reduced the risk of kidney disease progression by 37% overall, with comparable effects in patients with and ...
1. For sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists to be used as first-line agents for type ...
1. This population-based cohort study demonstrated that among older adults with type 2 diabetes, sodium-glucose cotransporter-2 inhibitor (SGLT-2i) use was ...
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in achieving target glycated hemoglobin levels in patients ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://s25qthea.wpenginepowered.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
1. No significant differences in vascular complications of diabetes were seen in patients using metformin and adjunctive glargine, liraglutide, glimepiride, ...
1. At week 16, average neuropathic pain score decreased for all three treatment groups. 2. Pain reduction was greater in ...
1. In patients with diabetic macular edema, aflibercept monotherapy showed no difference in vision improvement compared to step therapy of ...
1. In a retrospective cohort of about 3,000 children and young adults, new diagnoses of type 2 diabetes increased by ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.